Extensive Financial Ties Revealed Among Sleep Research Leaders
A comprehensive review of disclosed interests reveals significant financial relationships between prominent sleep researchers and a wide range of companies, institutions, and organizations, raising questions about potential influences on the field. The disclosures, detailed in recently released documentation, paint a picture of extensive collaboration – and potential conflicts – within the sleep science community.
Key Findings at a Glance
The analysis highlights financial connections involving multiple researchers, encompassing institutional support, consulting fees, research grants, equity holdings, and even royalty payments. These relationships span pharmaceutical companies, technology firms, airlines, and legal entities, demonstrating the broad commercial interest in sleep-related research and interventions.
Deep Dive into disclosed Interests
Several researchers reported considerable institutional support. MDW disclosed support from the US Centers for Disease Control and Prevention, the National Institutes of Occupational Safety and Health, and Delta Airlines, alongside consulting fees from the Fred Hutchinson Cancer Centre. SFQ reported institutional support from the National Institutes of Health and consulting fees from SleepRes,and Whispersom.
Harvard Professor’s Extensive Network
Perhaps the most extensive network of disclosed interests centers around CAC, a Harvard Medical School professor holding an endowed professorship provided by cephalon, Inc. This individual reports institutional support for a Quality Advancement Initiative from Delta Airlines and Puget Sound Pilots, and educational support to Harvard Medical School and Brigham and women’s Hospital from a multitude of sources including Jazz Pharmaceuticals PLC, Inc., Philips Respironics, Inc., Optum, and ResMed, Inc.
Research support to brigham and Women’s Hospital was also detailed, originating from Axome Therapeutics, Inc., Dayzz Ltd., Regeneron Pharmaceuticals, Sanofi SA, and the CDC Foundation, among others. Further financial ties include royalty payments from Philips Respironics, Inc. for the Actiwatch-2 and Actiwatch-Spectrum devices, consulting fees from Axome, Inc., Bryte Foundation, and Vanda Pharmaceuticals, and honoraria from organizations like the Associated Professional Sleep Societies, LLC.
Notably, CAC has also served as an expert witness in numerous legal cases involving companies such as Amtrak, Delta Airlines/Comair, FedEx, and Vanda Pharmaceuticals. Equity interests were also disclosed in Vanda pharmaceuticals, With Deep, Inc, and signos, Inc. Institutional gifts to Brigham and Women’s Hospital were received from Johnson & Johnson and other philanthropic organizations. According to a statement, CAC’s interests are reviewed and managed by the Brigham and Women’s Hospital and Mass General Brigham in accordance with their conflict-of-interest policies.
Non-Financial Disclosures and Broader Context
while the majority of disclosures pertain to financial interests, SFQ also reported serving on the scientific advisory board of healthy Hours and being a member of the 50th Anniversary committee for the American Academy of Sleep Medicine, receiving no compensation from either. The remaining authors listed in the documentation reported no relevant financial or non-financial interests to disclose.
These disclosures underscore the increasing commercialization of sleep research and the complex web of relationships between scientists, industry, and institutions. While collaboration can drive innovation, the extent of these financial ties warrants careful consideration and transparency to ensure the integrity and objectivity of scientific findings.
